Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto, Haerani Rasyid, Anastasya Angelica Vicente, Winny Suciangto

The diabetic patient with renal failure E. RITZ , M. SCHÖMING

Nutrition in chronic renal failure J. BERGSTRÖM